We found favipiravir improved the time to clinical cure by around three days," said the study's main author Dr Zarir F Udwadia. Patients who took the drug cleared the virus 30% (two days) faster than those on standard treatment. The study has been published in the peer-reviewed International Journal of Infectious Diseases. "This may not sound like a very big difference, but is significant. There are so few treatment options that when a drug gives even a promising signal, it's exciting news," said Dr Udwadia.
For reference to all site members.
Comments